Clemens Mayer

Clemens Mayer

Auto-generated profile, based on publicly available information

Clemens Mayer

Stratingh Institute for Chemistry University of Groningen Groningen The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Nature Reviews Chemistry
Verified
Journal Article
Closed access
PDF file
RLReuben B. Leveson-Gower
Reuben B. Leveson-Gower
CMClemens Mayer
Clemens Mayer
GRGerard Roelfes
Gerard Roelfes

2 July 2018 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
IDIvana Drienovská
Ivana Drienovská
CMClemens Mayer
Clemens Mayer
CDChristopher Dulson
Christopher Dulson
GRGerard Roelfes
Gerard Roelfes

21 December 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
CMClemens Mayer
Clemens Mayer
CDChristopher Dulson
Christopher Dulson
EREswar Reddem
Eswar Reddem
ATAndy-Mark Thunnissen
Andy-Mark Thunnissen
GRGerard Roelfes
Gerard Roelfes
The impressive rate accelerations that enzymes display in nature often result from boosting the inherent catalytic activities of side chains by their precise positioning inside a protein binding pocket. Such fine‐tuning is also possible for catalytic unnatural amino acids. Specifically, the directed evolution of a recently described designer enzyme, which utilizes an aniline side chain to promote a model hydrazone formation reaction, is reported. Consecutive rounds of directed evolution identified several mutations in the promiscuous binding pocket, in which the unnatural amino acid is embedded in the starting catalyst. When combined, these mutations boost the turnover frequency (kcat) of the designer enzyme by almost 100‐fold. This results from strengthening the catalytic contribution of the unnatural amino acid, as the engineered designer enzymes outperform variants, in which the aniline side chain is replaced with a catalytically inactive tyrosine residue, by more than 200‐fold.

26 June 2020 in Nature Catalysis
Verified
Journal Article
Closed access
PDF file
JOJim Ottelé
Jim Ottelé
AHAndreas S. Hussain
Andreas S. Hussain
CMClemens Mayer
Clemens Mayer
SOSijbren Otto
Sijbren Otto

16 February 2022 in Journal of the American Chemical Society
Verified
Journal Article
Open access
TOTitia Rixt Oppewal
Titia Rixt Oppewal
IJIvar D. Jansen
Ivar D. Jansen
JHJohan Hekelaar
Johan Hekelaar
CMClemens Mayer
Clemens Mayer
Macrocyclic peptides (MPs) have positioned themselves as a privileged class of compounds for the discovery of therapeutics and development of chemical probes. Aided by the development of powerful selection strategies, high-affinity binders against biomolecular targets can readily be elicited from massive, genetically encoded libraries by affinity selection. For example, in phage display, MPs are accessed on the surface of whole bacteriophages via disulfide formation, the use of (symmetric) crosslinkers, or the incorporation of non-canonical amino acids. To facilitate a straightforward cyclization of linear precursors with asymmetric molecular scaffolds, which are often found at the core of naturally occurring MPs, we report an efficient two-step strategy to access MPs via the programmed modification of a unique cysteine residue and an N-terminal amine. We demonstrate that this approach yields MPs featuring asymmetric cyclization units from both synthetic peptides and when linear precursors are appended onto a phage-coat protein. Finally, we showcase that our cyclization strategy is compatible with traditional phage-display protocols and enables the selection of MP binders against a model target protein from naïve libraries. By enabling the incorporation of non-peptidic moieties that (1) can serve as cyclization units, (2) provide interactions for binding, and/or (3) tailor pharmacological properties, our head-to-side-chain cyclization strategy provides access to a currently under-explored chemical space for the development of chemical probes and therapeutics.

8 April 2020 in Journal of the American Chemical Society
Verified
Journal Article
Open access
KLKim Chang Liu
Kim Chang Liu
KRKonstantin Röder
Konstantin Röder
CMClemens Mayer
Clemens Mayer
SASantosh Adhikari
Santosh Adhikari
DWDavid Wales
David Wales
SBShankar Balasubramanian
Shankar Balasubramanian
The study of G-quadruplexes (G4s) in a cellular context has demonstrated links between these nucleic acid secondary structures, gene expression and DNA replication. Ligands that bind to the G4 structure therefore present an excellent opportunity for influencing gene expression through the targeting of a nucleic acid structure rather than sequence. Here, we explore cyclic peptides as an alternative class of G4 ligands. Specifically, we describe the development of de novo G4-binding bicyclic peptides selected by phage display. Selected bicyclic peptides display sub-micromolar affinity to G4 structures and high selectivity over double helix DNA. Molecular simulations of the bicyclic peptide-G4 complexes corroborate the experimental binding strengths, and reveal molecular insights into G4 recognition by bicyclic peptides via the precise positioning of amino acid side chains, a binding mechanism reminiscent of endogenous G4-binding proteins. Overall, our results demonstrate that selection of (bi)cyclic peptides unlocks a privileged chemical space for targeting nucleic acid structures.